Phi Pharma SA
Development of drug conjugates
Phi Pharma SA is a private Swiss-based biopharmaceutical company. It specializes in the discovery and early clinical development of drug conjugates for improving treatment of diseases with high-medical need. Phi Pharma technology allows development of a powerful new class of peptide drug conjugates through specific cellular targeting and efficient intra-cellular delivery. Company programs are in oncology and infectious diseases.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
09.04.2018
Bilan: 50 Startups to invest in (startupticker.ch)
20.12.2016
Phi Pharma SA announces closing of CHF 3.7 million series A financing (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Phi Pharma SA
Development of drug conjugates
Website:
www.phi-pharma.com
Headquarter:
Sion
Foundation Date:
November 2011
Sectors:
- Drug development platforms